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Tenascin is a large glycoprotein of the extracellular matrix. 
Its complex multidomain structure, along with its unique 
distribution during embryogenesis, inflammation, wound 
healing, and tumorgenesis suggest this protein may play a 
significant ro~e .in regulati.ng ce!l prolif~ration, mi~ration, 
and differentlatlOn. In thiS review I Will summanze the 
T he extracellular matrix underlying the epidermis is thought to provide signals that regulate embryonic epidermal morphogenesis as well as normal prolifera-tion and terminal differentiation in adult epidermis [1,2]. Although devitalized dermis can support the 
growth and differentiation of epidermal keratinocytes, an active 
extracellular matrix that can sustain complete keratinocyte differ-
entiation has not yet been reconstituted from the major extracellular 
matrix proteins of the dermis and basement membrane zone. This 
has led to a growing interest in other extracellular matrix proteins 
that might regulate keratinocyte function. This review focuses on 
one of the less well known extracellular matrix proteins of the 
papillary dermis, tenascin. I will summarize the structural infonna-
tion on tenascin and present what is known about tenascin's poten-
tial role in the regulation of epidermal growth and differentiation. 
WHAT IS TENASCIN? 
Tenascin is a large glycoprotein of the extracellular matrix that has 
been independently discovered in a number oflaboratories (see [3,4] 
for reviews). Several names have been given to this protein includ-
ing glioma mesenchymal extracellular matrix protein (GMEM) , 
myotendinous antigen, hexabrachionlrotein, cytotactin, and J1. 
The term hexabrachion protein is use to describe the unique six-
armed structure of the tenascin molecule [5]. As shown in rotary-
shadowed images (Fig I), the tenascin molecule oligomer has six 
long, thin arms with the characteristic features of a terminal knob at 
the end of each arm (labeled a in Fig I), followed by a thick distal 
segment (- t of the arm, labeled b in Fig 1), a thin proximal segment (--!- of the arm, labeled c in Fig 1), a T-junction where three arms are 
joined to form a trimer (labeled d in Fig 1), and a central knob where 
two trimers arejoined to form a hexamer (labeled e in Fig 1). The six 
arms are identical (a homohexamer) and are joined by disulfide 
bonds at the T-junction and central knob [5,6]. 
A great deal has been learned about the molecular structure of 
tenascin. The complete sequence has been determined for chicken, 
mouse, human, and pig tenascin [7 - 10)' The predicted sequences 
allow a better understanding of the structure seen by rotary shadow-
ing. Following the putative leader sequence, the N-terminus of the 
molecule is unique to tenascin. It contains three heptad repeats 
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predicted to form a triple helical coiled coil structure similar to that 
seen in the long arm of laminin. Cysteine residues in this region are 
positioned to stabilize the coiled coil trimers and to link the trimers 
into hexamers [7,8]. Adjacent to tills amino-terminal domain re-
sponsible for multimer assembly is a region composed of epidermal 
growth factor (EGF)-like domains (14t in human TN, 13t in 
chicken) [7,8]. These form the thin proximal segment seen on ro-
tary shadowing. Following the EGF-like repeats is a stretch of do-
mains similar to the type III domains of fibronectin (FN-III do-
·mains). These form the thick distal segment seen on rotary 
shadowing. Eight of these domains are conserved and present in all 
known forms of TN [11] . In addition, up to eight alternatively 
spliced FN-III domains can be inserted between the conserved do-
mains 5 and 6 [8,12] . This leads to a variable molecular weight of 
220-320 kilodaltons (kD) for the human TN monomer. The 
C-terminus of TN has a domain that has homology to the C-ter-
minal domain of P- and y-fibrinogen [8] . This forms the terminal 
knob seen on rotary shadowing. 
The modular structure f~r the. tenascin arm is summarized in Fig 
2 [11]. Recent reports have Identified at least two new proteins with 
striki~gly si~ilar structu~es, suggesting that, analogous to laminin, 
there IS a family of tenasclll-related proteins [11,13 - 15] (see Fig 2). 
Like tenascin, these proteins have an N-terminal domain that could 
assemble into trimers followed by a string of EGF-like repeats, 
FN~III.-like domains, and a C-terminal fibrinogen domain. There 
IS slgmficant homology between the last three FN-III domains 
(FN-III 6-8) in these tenascin-related proteins, as well as the 
C-terminal fibrinogen domain, suggesting these may be very im-
portant functional domains [11]. As with the laminin family, a 
unifying nomenclature. for this group of related proteins has been 
proposed where tenaSCl11, the best studied of the group, would be 
called tenascin-C (for cytotactin, the first published sequence) 
[11,13]. . 
WHY MIGHT TENASCIN BE IMPORTANT IN SKIN? 
I~munohis~ochemic~1 studies reveal tenascin to be expressed in a 
tlme- and tissue-specific manner during embryonic development 
[3,4] .. -w.h~reas tenascin expression is widespread during embryo-
genesIs, It IS much more restricted thanlaminin or fibronectin. One 
~f the prominent sites of tenascin expression in embryos is at epithe-
hal mesenchymal interfaces, including skin, oral mucosa, lung, 
genitourinary tract, and gastrointestinal tract [16 - 21]. A striking 
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Figure 1. Rotary-shadowed image of human tenascin synthesized and se-
creted from human glioma cells in culture showing the characteristic six-
armed appearance. The accompanying sketch labels the main features of the 
molecule's structure discussed in the text. (Micrograph courtesy of Harold 
Erickson, Duke Universiry, Durham, NC.) 
finding is the appearance of tenascin in the mesenchyme coincident 
with morphogenetic events. In developing skin, tenascin is first 
present as a faint band at the dermal-epidermal junction as early as 
7 -8 weeks' gestation in humans (J InvestDermatoI90:582, 1988 and 
unpublished observations). However, studies on human and other 
mammalian fetal skin later in gestation (approximately 11-12 
weeks for human) reveal that tenascin expression is markedly in-
duced immediately beneath the epidermal buds that will differen-
tiate into adnexal structures including teeth, hair, and breast gland 
[19,20,22]. This is in contrast to fibronectin's diffuse expression in 
the dermis at this stage of development and has led to the specula-
tion that tenascin is a marker for epithelial-mesenchymal interac-
tions. . 
Whereas tenascin is absent in many adult tissues, it is present in 
normal adult skin as a thin, sometimes discontinuous, band in the 
papillary dermis immediately beneath the dermal-epidermal junc-
tion (Fig 3) [23]. Immunoelectron microscopy studies have shown 
tenascin is beneath the basement membrane zone and is not specifi-
cally associated with dermal collagen fibers (types I and III), an-
choring fibrils (collagen VII), or elastic fibers or rnicrofibrils (fibril-
lin) (Fig 4) [23,24]. 
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Figure 2. Domain structure of the tenascin family (TN-C for cytotactinj 
tenascin, TN-R for restrictin. and TN-X). This diagram is modified from 
[11]. where the features of the tenascin family are discussed in detail (re-
printed with permission of Current Biology, Ltd.). FN-III domains shown 
by ope/J squares are universal and numbered 1-5 and 6-8. Alternatively 
spliced FN-I1I domains are shaded and lettered based on highest degree of 
shared homology. (Figure courtesy of Harold Erickson, Duke Universiry. 
Durham, NC.) 
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Figure 3. Indirect immunoperoxidase staining of human skin using anti-
tenascin antibody (reproduced from] Cell Bioi 108:2483-2493. 1989. hy 
copyright permission of the Rockefeller Universiry Press). Bound antibody 
was detected using the ABC peroxidase method. Areas of staining include 
the parillary dermis (arrow) with increased staining around the infundibu-
lum 0 the hair follicle (arrowhead) . In addition, there is prominent staining 
of the ductal portion of eccrine sweat glands (opet1 arrows). 
Tenascin expression is markedly increased in the matrix 
surrounding tumors as well as during tissue restructuring, inflam-
mation, and wound healing [3,4,25]. Notably, conditions of in-
creased epidermal proliferation, including tape stripping, wound 
healing, and psoriasis (Fig 5), are associated with increased tenascin 
expression [20,23,25-29]. 
WHAT DOES TENASCIN DO? 
The association of tenascin expression coincident with epithelial 
morphogenesis, proliferation, and wound healing has led to the 
speculation that tenascin plays a significant role in these processes. 
However, direct evidence of tenascin's role in regulating cell func-
tion has been controversial. I will briefly summarize some of the 
stuqies that have been done on tenascin that relate to its potential 
role in the skin. 
Tenascin and Cell Adhesion Because of tenascin's modular 
structure and homology to the cell-adhesion domains of fibronec-
tin, many of the first studies on this glycoprotein focused on ten a-
scin's potential role in cell adhesion. There is considerable contro-
versy in the literature over the ability of tenascin to promote cell 
attachment, with some labs reporting adhesion [30,31], others no 
adhesion [20,32 - 34], and still others adhesion but no cell spreading 
[35 - 37]' The reason for these disparate results is not known. The 
source of tenascin as well as the cell types used in different studies 
have not been uniform. There could be latent adhesion domains in 
tenascin that are only accessible following partial degradation of the 
molecule. This is supported by several recent studies on recombi-
nant tenascin peptides as well as proteolytic fragments [35,38-42]. 
demonstrating cell-type specific adhesion to several tenascin do-
mains. Some of these adhesion sites are integrin dependent whereas 
others appear to be mediated by cell-surface proteoglycans 
[37,38,41]. Moreover, Joshi et al [38] have reported that cell ad he-
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Figure 4. Electron microscopic immunolocalization of tenascin in adult 
human skin (reproduced from1 Cell BioI 108:2483-2493, 1989, by copy-
right permission of the Rocketeller University Press) . Beneath the dermal-
epidermal junction, small amorphous patches are labeled with 10-nm gold. 
The patches are not specifically associated with collagen (solid arrows) or 
elastic fibers (opell arrolvs) in the dermis. No labeling of the basement mem-
brane or immediate sublamina zone is seen (lamina densa, large arrowhead; 
anchoring fibril, small arrowhead) . bIsel, rotary-shadowed tenascin molecule 
at the same magnification. 
sion to tenascin is dependent on both the type of surface to which it 
is attached and the length of time it is allowed to attach, suggesting 
there may be conformational changes that expose latent adhesion 
sites on the tenascin molecule. These findings may explain the 
diverse results reported in the literature. Additionally, because tena-
scin expression is frequently upregulated in conditions also asso-
ciated with increased secretion of matrix-degrading enzymes, it is 
possible that tenascin fragments are generated itz vivo and that these 
fragments have important physiologic roles. 
As first reported by Chiquet-Ehrismann el al [36], there is general 
agreement in the literature that tenascin has anti-adhesive proper-
ties. There appear to be at least two mechanisms mediating this 
effect. The first, a steric blocking of cell access to the matrix, does 
not require a specific cell receptor [33] . By a different mechanism, 
tenascin can also downregulate focal adhesions of cells already 
spread on fibronectin [43]. The responsible domain for this effect 
has been mapped to the alternately spliced region of tenascin in the 
FN-II1 domains. Chung et al (Mol Bioi Ce1l3:73a, 1992, manuscript 
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in preparation) have recently reported on a non-integrin cell-surface 
receptor that binds this domain but its role in downregulating focal 
adhesions is not known. It is clear from recent studies on proteolytic 
fragments of tenascin [40], fusion proteins [35] , and tenascin-block-
ing antibodies (unpublished results) that there are additional anti-
adhesive domains in tenascin. The mechanism for tenascin's direct 
effect on cell shape is not known. These kinds of changes in cell 
adhesion could potentially impact on all aspects of cell behavior 
including migration, proliferation, and organization into a func-
tional tissue. 
Tenascin and Cell Migration During embryogenesis, tenascin 
expression is induced coincident with cell migration, particularly in 
the developing nervous system [44-47]. In healing wounds, tena-
scin is induced early in the repair process [23,27,29] and it has been 
speculated that tenascin might enhance keratinocyte migration re-
quired for re-epithelization. We have fowld that tenascin alone 
Figure 5. Indirect immunoperoxidase staining of normal and lesional pso-
riatic skin using anti-tenascin antibody. Bound antibody was detected using 
the ABC peroxidase method. The narrow band of staining seen in the 
papillary dermis of normal skin (AJ is replaced by a broad dermal staining 
that spans the entire depth of the specimen in lesional psoriatic skin (B). 
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cannot promote keratinocyte migration (J Invest Dermatol100:524, 
1993, manuscript in preparation) . However, in doses equivalent to 
those synthesized by keratinocytes in vitro, tenascin enhances mi-
gration on permissive substrates such as type IV collagen and fibro-
nectin (J Invest Dermatol100:524, 1993). The enhancement effect 
requires the alternative splice region of tenascin, which correlates 
well with the findings of Kaplony et al [45], who reported that 
induction of the large splice form of tenascin immediately preceded 
corneal cell migration in the developing eye. It is possible that the 
effects of this domain on focal adhesions lead to a loosening of cell 
contacts with the underlying matrix to allow the cells to move 
forward over the wound bed. 
Tenascin and Cell Proliferation Tenascin expression is en-
hanced in conditions of increased proliferation, leading to the sug-
gestion that tenascin acts as a localized growth factor [48]. Whereas 
an early study by Chiquet-Ehrismann et al [20] reported that tena-
scin sustained serum-free growth of primary explants of mammary 
rumors, a more recent study on 3T3 fibroblasts by Crossin [49] 
found that tenascin inhibits DNA synthesis in rapidly proliferating 
cells. In contrast, End et al [50] have reported tenascin to be mito-
genic for quiescent 3T3 cell lines, an activity also seen with laminin 
[51]. We have found tenascin to have anti-proliferative effects on 
rapidly growing cultures of both human keratinocytes and dermal 
fibroblasts (Lightner and Erickson, in preparation). These studies 
raise the question of whether tenascin is acting as a mitogen or a 
growth regulator in vivo. 
Tenascin Knockout Mouse Whereas all of these studies suggest 
an essential function for tenascin in the morphogenesis, growth, 
and repair of the skin, the recent construction of a tenascin knockout 
mouse has raised many questions about the role of tenascin in the 
skin. As reported by Saga et al [52]' the tenascin minus mouse devel-
ops normally. These tenascin minus mice have normal-appearing 
skin, hair, and teeth and do not exhibit grossly abnormal wound 
healing. However, no detailed studies on wound healing, skin ten-
sile strength, hair cycling, or other skin responses have been con-
ducted on these mice. 
It is unlikely that tenascin has no function [53,54] . It is highly 
conserved in all vertebrates. The lack of a phenotype in the tenascin 
knockout mouse is not altogether surprising as a number of other 
gene deletions have shown surprisingly mild or undetectable phe-
notypes [53,55-59]. One possible explanation for the lack of phe-
notype is that compensatory changes in other extracellular matrix 
molecules, including other tenascin family members, make up for 
the lack of tenascin. Alternatively, the selective advantage afforded 
by tenascin could be subtle and not detected by the simple examina-
tion these mice have had. It is also possible that the selective advan-
tage of tenascin will only be seen when the animal is stressed, as was 
the case with the tumor necrosis factor (TNF}-a receptor 1 knock-
out mouse [58]. These questions will only be answered when de-
tailed studies on the tenascin knockout mice are completed. 
Thus, whereas the multidomain structure of tenascin and it in-
triguing pattern of expression in embryonic, adult, and pathogenic 
skin suggest tenascin may be a candidate for extracellular matrix/ 
epidermal signaling in skin, the true role of tenascin in the morpho-
genesis and homeostasis of the epidermis remains to be elucidated. 
I gratefully acknowledge tllf contrib~ltion oJDr. J:larold P. Ericksott, who contributed 
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ANNOUNCEMENT 
The 43rd Annual Symposium on the Biology of Skin will be held in Snowmass, Colorado 
August 6 - 10, 1994. The topic of this year's meeting will be "Lymphocytes in Skin Disease: 
From Activation to Immunodeficiency." 
The meeting will consist of invited oral and poster presentations. Enrollment is limited to 
150 participants. A limited number of posters will be accepted for presentation. Deadline for 
poster abstract submission is June 1, 1994. Those wishing to submit abstracts for poster presen-
tations or requesting registration materials should write to David A. Norris, M.D., The Cuta-
neous Biology Foundation, Box B-144, Department of Dermatology, University of Colorado 
School of Medicine, 4200 E. Ninth Avenue, Denver, CO 80262. 
